2.50Open2.50Pre Close0 Volume44 Open Interest5.00Strike Price0.00Turnover220.82%IV-18.48%PremiumDec 20, 2024Expiry Date4.20Intrinsic Value100Multiplier28DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9046Delta0.0301Gamma2.02Leverage Ratio-0.0175Theta0.0029Rho1.83Eff Leverage0.0043Vega
MiMedx Stock Discussion
In a recent move that underscores their confidence in the regenerative medicine sector, Mizuho Securities has maintained its 'Buy' rating on MiMedx Group Inc. (NASDAQ: MDXG) and has raised the price target from a previous estimate to $14. This comes as the company continues to make significant strides in its advanced wound care and surgical tissue solutions. $MiMedx (MDXG.US)$